Jeffrey A Schneider

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Small Cell Lung Cancer

Top Venues

JCO precision oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Justine Habault, Jeffrey A Schneider, Susan Ha, Rachel Ruoff, Luiza D Doro Pereira, Joseph Puccini, Michela Ranieri, Ruveyda Ayasun, Jiehui Deng, Amanda C Kasper, Dafna Bar-Sagi, Kwok-Kin Wong, Amina Zoubeidi, Frank Claessens, David R Wise, Susan K Logan, Kent Kirshenbaum, Michael J Garabedian
A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer. Molecular cancer therapeutics (2023)
David R Wise, Jeffrey A Schneider, Joshua Armenia, Victor Adorno Febles, Bridget McLaughlin, Ryan Brennan, Katie L Thoren, Wassim Abida, Karen S Sfanos, Angelo M De Marzo, Srinivasan Yegnasubramanian, Josef J Fox, Michael Haas, Heidi Heath, Michael H Kagey, Walter Newman, Cynthia A Sirard, Martin Fleisher, Michael J Morris, Yu Chen, Steven M Larson, Michael C Haffner, Peter S Nelson, Nikolaus Schultz, Michael J Garabedian, Howard I Scher, Susan K Logan, Charles L Sawyers, null null
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 4 (2020)